Image-based multichannel vaginal cylinder brachytherapy for the definitive treatment of gynecologic malignancies in the vagina.

[1]  B. Erickson,et al.  American Brachytherapy Society recurrent carcinoma of the endometrium task force patterns of care and review of the literature. , 2017, Brachytherapy.

[2]  B. Yaremko,et al.  A Phase III Randomized Trial Comparing Patient-Reported Toxicity and Quality of Life (QOL) During Pelvic Intensity Modulated Radiation Therapy as Compared to Conventional Radiation Therapy. , 2016 .

[3]  P. Catalano,et al.  Outcomes with image-based interstitial brachytherapy for vaginal cancer. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[4]  Christian Kirisits,et al.  Dose-volume effect relationships for late rectal morbidity in patients treated with chemoradiation and MRI-guided adaptive brachytherapy for locally advanced cervical cancer: Results from the prospective multicenter EMBRACE study. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[5]  Christian Kirisits,et al.  Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[6]  Christian Kirisits,et al.  Descriptive Analysis of Bladder Morbidity after Definitive Radiotherapy (±Chemotherapy) and Image Guided Adaptive Brachytherapy (IGABT) for Locally Advanced Cervical Cancer. A Report from the EMBRACE Study , 2016 .

[7]  Christian Kirisits,et al.  Bowel Morbidity in Locally Advanced Cervical Cancer Patients Treated with Combined External Beam Radiotherapy, Image-Guided Adaptive Brachytherapy (IGABT) and Concomitant Chemotherapy; a Descriptive Analysis from the Embrace Study , 2016 .

[8]  S. Beriwal,et al.  Multichannel vaginal cylinder brachytherapy-Impact of tumor thickness and location on dose to organs at risk. , 2015, Brachytherapy.

[9]  I. Hsu,et al.  Inverse Planned High-Dose-Rate Brachytherapy for Locoregionally Advanced Cervical Cancer: 4-Year Outcomes. , 2015, International journal of radiation oncology, biology, physics.

[10]  S. Beriwal,et al.  Brachytherapy for malignancies of the vagina in the 3D era , 2015, Journal of contemporary brachytherapy.

[11]  C. Houser,et al.  MRI-guided high-dose-rate intracavitary brachytherapy for treatment of cervical cancer: the University of Pittsburgh experience. , 2015, International journal of radiation oncology, biology, physics.

[12]  R. Cormack,et al.  A novel intracavitary applicator design for the treatment of deep vaginal fornices: preliminary dose metrics and geometric analysis , 2015, Journal of contemporary brachytherapy.

[13]  Yasir A. Bahadur,et al.  Single versus multichannel applicator in high-dose-rate vaginal brachytherapy optimized by inverse treatment planning , 2014, Journal of contemporary brachytherapy.

[14]  S. Beriwal,et al.  Extended field intensity modulated radiation therapy with concomitant boost for lymph node-positive cervical cancer: analysis of regional control and recurrence patterns in the positron emission tomography/computed tomography era. , 2014, International journal of radiation oncology, biology, physics.

[15]  M. Rajagopalan,et al.  Adoption and impact of concurrent chemoradiation therapy for vaginal cancer: a National Cancer Data Base (NCDB) study. , 2014, Gynecologic oncology.

[16]  I. Rutten,et al.  Improved survival of patients with cervical cancer treated with image-guided brachytherapy compared with conventional brachytherapy. , 2014, Gynecologic oncology.

[17]  E. M. Pedersen,et al.  Toward four-dimensional image-guided adaptive brachytherapy in locally recurrent endometrial cancer. , 2014, Brachytherapy.

[18]  C. Houser,et al.  Dosimetric comparison of multichannel with one single-channel vaginal cylinder for vaginal cancer treatments with high-dose-rate brachytherapy. , 2014, Brachytherapy.

[19]  A. Damato,et al.  Clinical outcomes following 3D image-guided brachytherapy for vaginal recurrence of endometrial cancer. , 2013, Gynecologic oncology.

[20]  Kari Tanderup,et al.  MRI-guided adaptive radiotherapy in locally advanced cervical cancer from a Nordic perspective , 2013, Acta oncologica.

[21]  C. Houser,et al.  Urethral dosimetry and toxicity with high-dose-rate interstitial brachytherapy for vaginal cancer. , 2013, Brachytherapy.

[22]  C. Haie-meder,et al.  Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: results of the French STIC prospective study. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[23]  J. Dimopoulos,et al.  Treatment of locally advanced vaginal cancer with radiochemotherapy and magnetic resonance image-guided adaptive brachytherapy: dose-volume parameters and first clinical results. , 2012, International journal of radiation oncology, biology, physics.

[24]  J. Dimopoulos,et al.  Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (IV): Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[25]  Christian Kirisits,et al.  Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[26]  G. Matanoski,et al.  Descriptive epidemiology of vaginal cancer incidence and survival by race, ethnicity, and age in the United States , 2008, Cancer.

[27]  D. Lowy,et al.  Assessing the Burden of HPV-Associated Cancers in the United States HPV Prophylactic Vaccines and the Potential Prevention of Noncervical Cancers in Both Men and Women , 2008 .

[28]  S. Davidson,et al.  Magnetic resonance imaging of primary vaginal carcinoma. , 2007, Clinical radiology.

[29]  Mitchell Morris,et al.  Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  A. Jhingran,et al.  Definitive radiotherapy for patients with isolated vaginal recurrence of endometrial carcinoma after hysterectomy. , 2003, International journal of radiation oncology, biology, physics.

[31]  S. Nag,et al.  A simple method of obtaining equivalent doses for use in HDR brachytherapy. , 2000, International journal of radiation oncology, biology, physics.

[32]  T. Wong,et al.  The use and advantages of a multichannel vaginal cylinder in high-dose-rate brachytherapy. , 1999, International journal of radiation oncology, biology, physics.

[33]  S. Nag,et al.  Perineal template interstitial brachytherapy salvage for recurrent endometrial adenocarcinoma metastatic to the vagina. , 1997, Gynecologic oncology.

[34]  K. Greven,et al.  Prognostic factors and treatment outcome for patients with locally recurrent endometrial cancer , 1994, Cancer.

[35]  C. Kirisits,et al.  Dose-effect relationship and risk factors for vaginal stenosis after definitive radio(chemo)therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[36]  A. Jemal,et al.  Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.

[37]  M. Rajagopalan,et al.  Patterns of care and brachytherapy boost utilization for vaginal cancer in the United States. , 2015, Practical radiation oncology.

[38]  C. Houser,et al.  Image-based multichannel vaginal cylinder brachytherapy for vaginal cancer. , 2015, Brachytherapy.

[39]  J. Rownd,et al.  American Brachytherapy Society consensus guidelines for interstitial brachytherapy for vaginal cancer. , 2012, Brachytherapy.

[40]  R. Stock,et al.  A 30-year experience in the management of primary carcinoma of the vagina: analysis of prognostic factors and treatment modalities. , 1995, Gynecologic oncology.